These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 32111066)

  • 21. Nicotinamide adenine dinucleotide (NAD+): essential redox metabolite, co-substrate and an anti-cancer and anti-ageing therapeutic target.
    Griffiths HBS; Williams C; King SJ; Allison SJ
    Biochem Soc Trans; 2020 Jun; 48(3):733-744. PubMed ID: 32573651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Alkylating Chemotherapeutic Temozolomide Induces Metabolic Stress in
    Tateishi K; Higuchi F; Miller JJ; Koerner MVA; Lelic N; Shankar GM; Tanaka S; Fisher DE; Batchelor TT; Iafrate AJ; Wakimoto H; Chi AS; Cahill DP
    Cancer Res; 2017 Aug; 77(15):4102-4115. PubMed ID: 28625978
    [No Abstract]   [Full Text] [Related]  

  • 23. Recent advances of targeting nicotinamide phosphoribosyltransferase (NAMPT) for cancer drug discovery.
    Tang H; Wang L; Wang T; Yang J; Zheng S; Tong J; Jiang S; Zhang X; Zhang K
    Eur J Med Chem; 2023 Oct; 258():115607. PubMed ID: 37413882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutant IDH1 Differently Affects Redox State and Metabolism in Glial Cells of Normal and Tumor Origin.
    Biedermann J; Preussler M; Conde M; Peitzsch M; Richter S; Wiedemuth R; Abou-El-Ardat K; Krüger A; Meinhardt M; Schackert G; Leenders WP; Herold-Mende C; Niclou SP; Bjerkvig R; Eisenhofer G; Temme A; Seifert M; Kunz-Schughart LA; Schröck E; Klink B
    Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31888244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NAD(P) biosynthesis enzymes as potential targets for selective drug design.
    Magni G; Di Stefano M; Orsomando G; Raffaelli N; Ruggieri S
    Curr Med Chem; 2009; 16(11):1372-90. PubMed ID: 19355893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative importance of redox buffers GSH and NAD(P)H in age-related neurodegeneration and Alzheimer disease-like mouse neurons.
    Ghosh D; Levault KR; Brewer GJ
    Aging Cell; 2014 Aug; 13(4):631-40. PubMed ID: 24655393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modification of NAD-dependent isocitrate dehydrogenase by the 2',3'-dialdehyde derivatives of NAD, NADH, NADP, and NADPH.
    Saha A; Colman RF
    Arch Biochem Biophys; 1988 Aug; 264(2):665-77. PubMed ID: 3401017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting isocitrate dehydrogenase (IDH) in cancer.
    Fujii T; Khawaja MR; DiNardo CD; Atkins JT; Janku F
    Discov Med; 2016 May; 21(117):373-80. PubMed ID: 27355333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nampt/PBEF/visfatin and cancer.
    Bi TQ; Che XM
    Cancer Biol Ther; 2010 Jul; 10(2):119-25. PubMed ID: 20647743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thiophenyl Derivatives of Nicotinamide Are Metabolized by the NAD Salvage Pathway into Unnatural NAD Derivatives That Inhibit IMPDH and Are Toxic to Peripheral Nerve Cancers.
    Theodoropoulos PC; Guo HH; Wang W; Crossley E; Rivera Cancel G; Fang M; Nguyen T; Baniasadi H; Williams NS; Ready JM; De Brabander JK; Nijhawan D
    ACS Chem Biol; 2024 Jun; 19(6):1339-1350. PubMed ID: 38829020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NAD+ depletion radiosensitizes 2-DG-treated glioma cells by abolishing metabolic adaptation.
    Shi X; Zhang W; Gu C; Ren H; Wang C; Yin N; Wang Z; Yu J; Liu F; Zhang H
    Free Radic Biol Med; 2021 Jan; 162():514-522. PubMed ID: 33197538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-proliferation effect of APO866 on C6 glioblastoma cells by inhibiting nicotinamide phosphoribosyltransferase.
    Zhang LY; Liu LY; Qie LL; Ling KN; Xu LH; Wang F; Fang SH; Lu YB; Hu H; Wei EQ; Zhang WP
    Eur J Pharmacol; 2012 Jan; 674(2-3):163-70. PubMed ID: 22119381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitochondrial isocitrate dehydrogenase and isocitrate oxidation of rat ventral prostate.
    Costello LC; Franklin R; Stacey R
    Enzyme; 1976; 21(6):495-506. PubMed ID: 12937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NAD
    Kennedy BE; Sharif T; Martell E; Dai C; Kim Y; Lee PW; Gujar SA
    Pharmacol Res; 2016 Dec; 114():274-283. PubMed ID: 27816507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of NAMPT markedly enhances plasma-activated medium-induced cell death in human breast cancer MDA-MB-231 cells.
    Nagaya M; Hara H; Kamiya T; Adachi T
    Arch Biochem Biophys; 2019 Nov; 676():108155. PubMed ID: 31628926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The NAD
    Murphy JP; Giacomantonio MA; Paulo JA; Everley RA; Kennedy BE; Pathak GP; Clements DR; Kim Y; Dai C; Sharif T; Gygi SP; Gujar S
    Cell Rep; 2018 Aug; 24(9):2381-2391.e5. PubMed ID: 30157431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isocitrate dehydrogenase mutation as a therapeutic target in gliomas.
    Han CH; Batchelor TT
    Chin Clin Oncol; 2017 Jun; 6(3):33. PubMed ID: 28705010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A fluorometric assay for high-throughput screening targeting nicotinamide phosphoribosyltransferase.
    Zhang RY; Qin Y; Lv XQ; Wang P; Xu TY; Zhang L; Miao CY
    Anal Biochem; 2011 May; 412(1):18-25. PubMed ID: 21211508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of nicotinamide phosphoribosyltransferase modifies LPS-induced inflammatory responses of human monocytes.
    Schilling E; Wehrhahn J; Klein C; Raulien N; Ceglarek U; Hauschildt S
    Innate Immun; 2012 Jun; 18(3):518-30. PubMed ID: 21975728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of small-molecule urea derivatives as novel NAMPT inhibitors via pharmacophore-based virtual screening.
    Ozgencil F; Eren G; Ozkan Y; Guntekin-Ergun S; Cetin-Atalay R
    Bioorg Med Chem; 2020 Jan; 28(1):115217. PubMed ID: 31818629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.